David Erlinge

31.9k total citations · 3 hit papers
455 papers, 13.8k citations indexed

About

David Erlinge is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Erlinge has authored 455 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 287 papers in Cardiology and Cardiovascular Medicine, 125 papers in Surgery and 111 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Erlinge's work include Acute Myocardial Infarction Research (140 papers), Cardiac Imaging and Diagnostics (108 papers) and Antiplatelet Therapy and Cardiovascular Diseases (87 papers). David Erlinge is often cited by papers focused on Acute Myocardial Infarction Research (140 papers), Cardiac Imaging and Diagnostics (108 papers) and Antiplatelet Therapy and Cardiovascular Diseases (87 papers). David Erlinge collaborates with scholars based in Sweden, United States and Denmark. David Erlinge's co-authors include Stefan James, Matthias Götberg, Tomas Jernberg, Lars Edvinsson, Olof Gidlöf, Oscar Ö. Braun, Bertil Lindahl, Lingwei Wang, Sasha Koul and Geoffrey Burnstock and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

David Erlinge

431 papers receiving 13.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease

2017 309 citations Bertil Lindahl, Tomasz Baron et al. Circulation profile →
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014

2017 276 citations Karolina Szummer, Lars Wallentin et al. European Heart Journal profile →
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

2024 99 citations Troels Yndigegn, Bertil Lindahl et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David Erlinge	6.9k	3.1k	2.5k	2.1k	2.1k	455	13.8k
Masafumi Kitakaze	8.2k 1.2×	3.1k 1.0×	6.1k 2.4×	874 0.4×	1.7k 0.8×	474	19.4k
Dirk J. Duncker	7.7k 1.1×	2.4k 0.8×	2.9k 1.1×	246 0.1×	1.2k 0.6×	392	14.1k
Kazuaki Shimamoto	5.7k 0.8×	2.2k 0.7×	3.6k 1.4×	279 0.1×	822 0.4×	449	14.4k
Italo Biaggioni	7.8k 1.1×	7.7k 2.5×	2.4k 0.9×	2.9k 1.4×	195 0.1×	343	18.0k
Johann Bauersachs	10.9k 1.6×	5.3k 1.7×	8.0k 3.1×	185 0.1×	729 0.3×	577	24.6k
Walter Zidek	4.1k 0.6×	2.1k 0.7×	2.8k 1.1×	996 0.5×	169 0.1×	445	13.1k
Javed Butler	11.4k 1.7×	2.1k 0.7×	2.2k 0.9×	119 0.1×	639 0.3×	406	16.0k
Burkert Pieske	24.5k 3.6×	3.8k 1.3×	7.4k 2.9×	184 0.1×	672 0.3×	594	31.5k
Akira Kitabatake	7.3k 1.1×	3.5k 1.2×	2.8k 1.1×	117 0.1×	374 0.2×	380	14.5k
Borja Ibáñez	5.7k 0.8×	2.4k 0.8×	2.6k 1.0×	78 0.0×	823 0.4×	323	11.6k

Countries citing papers authored by David Erlinge

Since Specialization

Citations

This map shows the geographic impact of David Erlinge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Erlinge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Erlinge more than expected).

Fields of papers citing papers by David Erlinge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Erlinge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Erlinge. The network helps show where David Erlinge may publish in the future.

Co-authorship network of co-authors of David Erlinge

This figure shows the co-authorship network connecting the top 25 collaborators of David Erlinge. A scholar is included among the top collaborators of David Erlinge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Erlinge. David Erlinge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mohammad, Moman A., Sasha Koul, Troels Yndigegn, et al.. (2024). Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry. International Journal of Cardiology. 419. 132726–132726. 1 indexed citations

Redfors, Björn, Truls Råmunddal, Oskar Angerås, et al.. (2024). Importance of hospital and clinical factors for early mortality in Takotsubo syndrome: Insights from the Swedish Coronary Angiography and Angioplasty Registry. BMC Cardiovascular Disorders. 24(1). 359–359.

Mohammad, Moman A., Peter A. Merkel, Martin Englund, et al.. (2024). Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden. RMD Open. 10(2). e003960–e003960.

Andell, Pontus, Göran Olivecrona, Matthias Götberg, et al.. (2023). Intracoronary Imaging of Proximal Coronary Artery Lesions – A Nationwide Lesion-Level Analysis From SCAAR. Journal of the Society for Cardiovascular Angiography & Interventions. 2(3). 100597–100597. 1 indexed citations

Koul, Sasha, Elmir Ömerovic, John Andersson, et al.. (2023). Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry. European Heart Journal. 44(Supplement_2). 1 indexed citations

Bikdeli, Behnood, David Erlinge, Marco Valgimigli, et al.. (2023). Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials. Circulation. 148(16). 1207–1219. 15 indexed citations

Rylance, Rebecca, Philippe Wagner, Elmir Ömerovic, et al.. (2021). Assessing the external validity of the VALIDATE-SWEDEHEART trial. Clinical Trials. 18(4). 427–435. 1 indexed citations

Aktaa, Suleman, Gorav Batra, Lars Wallentin, et al.. (2020). European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes. European Heart Journal - Quality of Care and Clinical Outcomes. 8(1). 4–13. 42 indexed citations

Edfors, Robert, Lars Lindhagen, Jonas Spaak, et al.. (2020). Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction. Journal of Internal Medicine. 288(5). 581–592. 8 indexed citations

10.

Haraldsson, Inger, Sara Svedlund, Björn Redfors, et al.. (2019). PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Wallentin, Lars, Joakim Alfredsson, David Erlinge, et al.. (2019). Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. European Heart Journal. 41(7). 833–843. 46 indexed citations

12.

Venetsanos, Dimitrios, Tomas Lindahl, Sofia Sederholm Lawesson, et al.. (2018). Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention. Thrombosis Research. 171. 38–44. 3 indexed citations

13.

Lindahl, Bertil, Tomasz Baron, David Erlinge, et al.. (2017). Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease. Circulation. 135(16). 1481–1489. 309 indexed citations breakdown →

14.

Mohammad, Moman A., Iréne Lang, Michael Hölzer, et al.. (2017). Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy. Therapeutic Hypothermia and Temperature Management. 7(3). 152–161. 8 indexed citations

15.

Madder, Ryan D., Gregg W. Stone, David Erlinge, & James E. Muller. (2013). The Search for Vulnerable Plaque - The Pace Quickens. Lund University Publications (Lund University). 8 indexed citations

16.

Dixon, Simon, Hans Friberg, Magnus Öhman, & David Erlinge. (2011). Developing Clinical Trial in Acute Myocardial Infarction. Therapeutic Hypothermia and Temperature Management. 1(3). 123–127. 1 indexed citations

17.

Erlinge, David. (2011). A Review of Mild Hypothermia as an Adjunctive Treatment for ST-Elevation Myocardial Infarction. Therapeutic Hypothermia and Temperature Management. 1(3). 129–141. 23 indexed citations

18.

Lood, Christian, Stefan Amisten, Birgitta Gullstrand, et al.. (2010). Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood. 116(11). 1951–1957. 157 indexed citations

19.

Pals, Jesper van der, Sasha Koul, Patrik Gilje, et al.. (2010). Inhibition of c5a related neutrophil activation by adc-1004 reduces myocardial infarct in a porcine ischemia-reperfusion model. Lund University Publications (Lund University). 1 indexed citations

20.

Hillaire‐Buys, Dominique, J Chapal, Nathalie Linck, et al.. (1998). Cellular Responses and Integrative Physiology. Drug Development Research. 43(1). 45–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact